Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate
A E Steen1, K H Steen, R Bauer
1Department of Dermatology, Friedrich-Wilhelms University, Sigmund Freud Str. 25, D-53105 Bonn, Germany.
The British Journal of Dermatology
|July 17, 2001
Abstract:
Langerhans cell histiocytosis (LCH) can be a difficult therapeutic problem. We present a 40-year-old woman with a 4-year history of LCH who was successfully treated with low-dose methotrexate (20 mg weekly).